Stocks
Health Care
avtx
Avalo Therapeutics
NASDAQ: AVTX
-0.87 (-5.09%)
16.23
USD
At close at Mar 12, 14:40 UTC
Income Statement
Revenue
441.00K
Gross Profit
887.00K
Operating Income
-
Pretax Income
-99.84M
Net Income
-62.31M
EBITDA
-
EBIT
-46.10M
Earnings Per Share
-31.724400000000003
Balance Sheet
Cash & Cash Equivalents
125.05M
Total Debt
-
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
133.032
Book Value Per Share
12.7037
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.